Detalhe da pesquisa
1.
Izokibep for the treatment of moderate-to-severe plaque psoriasis: a phase II, randomized, placebo-controlled, double-blind, dose-finding multicentre study including long-term treatment.
Br J Dermatol
; 189(4): 381-391, 2023 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37697683
2.
Exposure-response analyses demonstrate no evidence of interleukin 17A contribution to efficacy of ABT-122 in rheumatoid or psoriatic arthritis.
Rheumatology (Oxford)
; 58(2): 352-360, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30376130
3.
Dual inhibition of tumour necrosis factor and interleukin-17A with ABT-122: open-label long-term extension studies in rheumatoid arthritis or psoriatic arthritis.
Rheumatology (Oxford)
; 57(11): 1972-1981, 2018 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30032191
4.
A randomized, clinical trial to assess the relative efficacy and tolerability of two doses of etoricoxib versus naproxen in patients with ankylosing spondylitis.
BMC Musculoskelet Disord
; 17(1): 426, 2016 10 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-27737664
5.
Evaluation of two doses of etoricoxib, a COX-2 selective non-steroidal anti-inflammatory drug (NSAID), in the treatment of Rheumatoid Arthritis in a double-blind, randomized controlled trial.
BMC Musculoskelet Disord
; 17: 331, 2016 08 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27502582
6.
Inadequate pain relief and large functional loss among patients with knee osteoarthritis: evidence from a prospective multinational longitudinal study of osteoarthritis real-world therapies.
Rheumatology (Oxford)
; 54(2): 270-7, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25150513
7.
Do COX-2 inhibitors provide additional pain relief and anti-inflammatory effects in patients with rheumatoid arthritis who are on biological disease-modifying anti-rheumatic drugs and/or corticosteroids? Post-hoc analyses from a randomized clinical trial with etoricoxib.
BMC Musculoskelet Disord
; 16: 26, 2015 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-25886874
8.
Evaluation of etoricoxib in patients undergoing total knee replacement surgery in a double-blind, randomized controlled trial.
BMC Musculoskelet Disord
; 14: 300, 2013 Oct 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-24156640
9.
Izokibep: Preclinical development and first-in-human study of a novel IL-17A neutralizing Affibody molecule in patients with plaque psoriasis.
MAbs
; 15(1): 2209920, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37184136
10.
Dual-Energy Computed Tomography Has Additional Prognostic Value Over Clinical Measures in Gout Including Tophi: A Systematic Literature Review.
J Rheumatol
; 49(11): 1256-1268, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35840151
11.
A multicentre, efficacy and safety study of methotrexate to increase response rates in patients with uncontrolled gout receiving pegloticase (MIRROR): 12-month efficacy, safety, immunogenicity, and pharmacokinetic findings during long-term extension of an open-label study.
Arthritis Res Ther
; 24(1): 208, 2022 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36008814
12.
Predictors of response to cyclo-oxygenase-2 inhibitors in osteoarthritis: pooled results from two identical trials comparing etoricoxib, celecoxib, and placebo.
Pain Med
; 12(3): 352-61, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21332932
13.
Longitudinal numbers-needed-to-treat (NNT) for achieving various levels of analgesic response and improvement with etoricoxib, naproxen, and placebo in ankylosing spondylitis.
BMC Musculoskelet Disord
; 12: 165, 2011 Jul 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-21767407
14.
Pegloticase in Combination With Methotrexate in Patients With Uncontrolled Gout: A Multicenter, Open-label Study (MIRROR).
J Rheumatol
; 48(5): 767-774, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32934137
15.
Reducing Immunogenicity of Pegloticase With Concomitant Use of Mycophenolate Mofetil in Patients With Refractory Gout: A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial.
Arthritis Rheumatol
; 73(8): 1523-1532, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33750034
16.
Course and prognostic factors for neck pain in workers: results of the Bone and Joint Decade 2000-2010 Task Force on Neck Pain and Its Associated Disorders.
J Manipulative Physiol Ther
; 32(2 Suppl): S108-16, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19251059
17.
Assessment of neck pain and its associated disorders: results of the Bone and Joint Decade 2000-2010 Task Force on Neck Pain and Its Associated Disorders.
J Manipulative Physiol Ther
; 32(2 Suppl): S117-40, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19251060
18.
Treatment of neck pain: noninvasive interventions: results of the Bone and Joint Decade 2000-2010 Task Force on Neck Pain and Its Associated Disorders.
J Manipulative Physiol Ther
; 32(2 Suppl): S141-75, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19251061
19.
A new conceptual model of neck pain: linking onset, course, and care: the Bone and Joint Decade 2000-2010 Task Force on Neck Pain and Its Associated Disorders.
J Manipulative Physiol Ther
; 32(2 Suppl): S17-28, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19251062
20.
Research priorities and methodological implications: the Bone and Joint Decade 2000-2010 Task Force on Neck Pain and Its Associated Disorders.
J Manipulative Physiol Ther
; 32(2 Suppl): S244-51, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19251070